193 related articles for article (PubMed ID: 24002436)
1. Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs.
Xu Y; Xie Y; Wang X; Chen X; Liu Q; Ying M; Zheng Q
Oncol Rep; 2013 Nov; 30(5):2056-62. PubMed ID: 24002436
[TBL] [Abstract][Full Text] [Related]
2. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
[TBL] [Abstract][Full Text] [Related]
3. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
Zhuo L; Liu J; Wang B; Gao M; Huang A
Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
[TBL] [Abstract][Full Text] [Related]
4. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
5. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
8. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
[TBL] [Abstract][Full Text] [Related]
9. Characterization of side population cells in human malignant mesothelioma cell lines.
Kai K; D'Costa S; Yoon BI; Brody AR; Sills RC; Kim Y
Lung Cancer; 2010 Nov; 70(2):146-51. PubMed ID: 20493579
[TBL] [Abstract][Full Text] [Related]
10. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y
BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470
[TBL] [Abstract][Full Text] [Related]
11. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
[TBL] [Abstract][Full Text] [Related]
12. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H
J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739
[TBL] [Abstract][Full Text] [Related]
13. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.
Gu Y; Wei X; Sun Y; Gao H; Zheng X; Wong LL; Jin L; Liu N; Hernandez B; Peplowska K; Zhao X; Zhan QM; Feng XH; Tang ZY; Ji J
Cancer Res; 2019 Mar; 79(5):941-953. PubMed ID: 30530815
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
[TBL] [Abstract][Full Text] [Related]
15. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
[TBL] [Abstract][Full Text] [Related]
16. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
17. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
[TBL] [Abstract][Full Text] [Related]
18. [Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].
Zhao Y; Jia HL; Zhou HJ; Dong QZ; Fu LY; Yan ZW; Sun J; Ren N; Ye QH; Qin LX
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):526-30. PubMed ID: 19912688
[TBL] [Abstract][Full Text] [Related]
19. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell.
Zhou J; Wang W
J Surg Oncol; 2011 Sep; 104(3):278-83. PubMed ID: 21495032
[TBL] [Abstract][Full Text] [Related]
20. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
